Pharmaceutical Technology1h
Roche to acquire Poseida Therapeutics for $1.5bn
Roche has signed an agreement for the acquisition of Poseida Therapeutics in a deal representing a total value of up to ...
Pharmaceutical Technology3h
Shorla Oncology’s IMKELDI approved by FDA for leukaemia cancers
The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...
Pharmaceutical Technology3h
Pharmaceutical Technology Excellence Awards 2024: PCI Pharma Services
PCI Pharma Services is a winner in the Innovation and Business Expansion categories in the 2024 Pharmaceutical Technology ...
Pharmaceutical Technology23h
GSK eyes up combo approval for previously withdrawn myeloma drug
The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.
Pharmaceutical Technology18h
Adcendo raises $135m as ADC funding frenzy continues
Founded in 2017 as a spin-out from the University of Copenhagen and Rigshospitalet, Adcendo previously raised $102.8m (€98m) ...
Pharmaceutical Technology20h
GSK gains approval in Japan for extended indication of RSV vaccine
GSK has received approval from Japan's MHLW for its application to extend the indication of its RSV vaccine, Arexvy.
Pharmaceutical Technology19h
Sustainability in biopharma: Collaboration and technology light the way forward
The biopharmaceutical industry is being called to take its sustainability efforts to the next level. A new report sheds light ...
Pharmaceutical Technology22h
Trump’s presidency return: boom or bust for biopharmaceutical deal activity?
On 5 November 2024, former US president Donald Trump was elected to a second term in the US presidential election.